Olympus Acquires BioProtect to Expand Oncology and Urology Provision

Olympus has finalized an agreement to acquire Israel-based BioProtect in a $270 million transaction. This acquisition focuses on advancing prostate cancer care through the integration of the Balloon Spacer system, a medical device that protects healthy tissue during radiation therapies. The acquisition equips Olympus with BioProtect’s primary product, the Balloon Spacer. Designed to biodegrade naturally […]

The post Olympus Acquires BioProtect to Expand Oncology and Urology Provision first appeared on HHM Global | B2B Online Platform & Magazine.